Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 119
mi
from
Charleston, WV
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 119
mi
from
Charleston, WV
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 007
mi
from
Middleton, WI
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 007
mi
from
Middleton, WI
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 138
mi
from
Milwaukee, WI
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 138
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Source of Hand Weakness After Stroke
Source of Neurally-Mediated Hand Weakness After Stroke
Status: Enrolling
Updated:  8/31/2012
Edward Hines,Jr., VA Hospital
mi
from
Hines, IL
Source of Hand Weakness After Stroke
Source of Neurally-Mediated Hand Weakness After Stroke
Status: Enrolling
Updated: 8/31/2012
Edward Hines,Jr., VA Hospital
mi
from
Hines, IL
Click here to add this to my saved trials
PC-Based Cognitive Rehabilitation for Traumatic Brain Injury (TBI)
PC-Based Cognitive Rehabilitation for TBI
Status: Enrolling
Updated:  9/6/2012
VA Northern California HCS
mi
from
Martinez, CA
PC-Based Cognitive Rehabilitation for Traumatic Brain Injury (TBI)
PC-Based Cognitive Rehabilitation for TBI
Status: Enrolling
Updated: 9/6/2012
VA Northern California HCS
mi
from
Martinez, CA
Click here to add this to my saved trials
Divalproex Sodium for Mood Swings and Alcohol Use Following Head Injury.
A Double Blind Trial Of Divalproex Sodium For Affective Lability And Alcohol Use Following Traumatic Brain Injury
Status: Enrolling
Updated:  9/6/2012
Denver Veterans Affairs Medical Center
mi
from
Denver, CO
Divalproex Sodium for Mood Swings and Alcohol Use Following Head Injury.
A Double Blind Trial Of Divalproex Sodium For Affective Lability And Alcohol Use Following Traumatic Brain Injury
Status: Enrolling
Updated: 9/6/2012
Denver Veterans Affairs Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
The Value of Traction in the Treatment of Cervical Radiculopathy
The Value of Mechanical Traction in the Treatment of Cervical Radiculopathy
Status: Enrolling
Updated:  9/11/2012
Intermountain Healthcare, Rehab Agency
mi
from
Salt Lake City, UT
The Value of Traction in the Treatment of Cervical Radiculopathy
The Value of Mechanical Traction in the Treatment of Cervical Radiculopathy
Status: Enrolling
Updated: 9/11/2012
Intermountain Healthcare, Rehab Agency
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
The Value of Traction in the Treatment of Cervical Radiculopathy
The Value of Mechanical Traction in the Treatment of Cervical Radiculopathy
Status: Enrolling
Updated:  9/11/2012
Wilford Hall Medical Center
mi
from
Lackland AFB, TX
The Value of Traction in the Treatment of Cervical Radiculopathy
The Value of Mechanical Traction in the Treatment of Cervical Radiculopathy
Status: Enrolling
Updated: 9/11/2012
Wilford Hall Medical Center
mi
from
Lackland AFB, TX
Click here to add this to my saved trials
Add on Lacosamide Versus High Dose Monotherapy
Open Label Trial of Add on Lacosamide Versus High Dose Monotherapy in Patients With a Seizure Disorder
Status: Enrolling
Updated:  9/12/2012
Brigham and Women's Hosp
mi
from
Boston, MA
Add on Lacosamide Versus High Dose Monotherapy
Open Label Trial of Add on Lacosamide Versus High Dose Monotherapy in Patients With a Seizure Disorder
Status: Enrolling
Updated: 9/12/2012
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Approaches to Auditory Rehabilitation for Mild Traumatic Brain Injury
Evaluation of Approaches to Auditory Rehabilitation for Mild TBI
Status: Enrolling
Updated:  9/13/2012
James A. Haley Veterans Hospital, Tampa
mi
from
Tampa, FL
Approaches to Auditory Rehabilitation for Mild Traumatic Brain Injury
Evaluation of Approaches to Auditory Rehabilitation for Mild TBI
Status: Enrolling
Updated: 9/13/2012
James A. Haley Veterans Hospital, Tampa
mi
from
Tampa, FL
Click here to add this to my saved trials
Approaches to Auditory Rehabilitation for Mild Traumatic Brain Injury
Evaluation of Approaches to Auditory Rehabilitation for Mild TBI
Status: Enrolling
Updated:  9/13/2012
VA Medical Center, Portland
mi
from
Portland, OR
Approaches to Auditory Rehabilitation for Mild Traumatic Brain Injury
Evaluation of Approaches to Auditory Rehabilitation for Mild TBI
Status: Enrolling
Updated: 9/13/2012
VA Medical Center, Portland
mi
from
Portland, OR
Click here to add this to my saved trials
Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis & Stroke-like Episodes
A Phase IIa Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis and Stroke-like Episodes
Status: Enrolling
Updated:  9/25/2012
Columbia University Medical Center
mi
from
New York, NY
Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis & Stroke-like Episodes
A Phase IIa Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis and Stroke-like Episodes
Status: Enrolling
Updated: 9/25/2012
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
University of Arizona Arthritis Center
mi
from
Tucson, AZ
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
University of Arizona Arthritis Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
UCLA Medical School - Rheumatology Division Rehabilitation Center
mi
from
Los Angeles, CA
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
UCLA Medical School - Rheumatology Division Rehabilitation Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
Arthritis and Rheumatic Disease Specialties
mi
from
Aventura, FL
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
Arthritis and Rheumatic Disease Specialties
mi
from
Aventura, FL
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
Sarasota Arthritis Research Center
mi
from
Sarasota, FL
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
Sarasota Arthritis Research Center
mi
from
Sarasota, FL
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
Ochsner Medical Center
mi
from
New Orleans, LA
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
Ochsner Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
The Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
The Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
University of Michigan-Scleroderma Program
mi
from
Ann Arbor, MI
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
University of Michigan-Scleroderma Program
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
Michigan State University
mi
from
East Lansing, MI
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
Michigan State University
mi
from
East Lansing, MI
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
University of Medicine & Dentistry of New Jersey, UMDNJ Scleroderma Program
mi
from
New Brunswick, NJ
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
University of Medicine & Dentistry of New Jersey, UMDNJ Scleroderma Program
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
Center for Rheumatology
mi
from
Albany, NY
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
Center for Rheumatology
mi
from
Albany, NY
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
Shanahan Rheumatology and Immunotherapy, PLLC
mi
from
Raleigh, NC
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
Shanahan Rheumatology and Immunotherapy, PLLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
Altoona Center for Clinical Research
mi
from
, PA
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
Altoona Center for Clinical Research
mi
from
, PA
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
University of Pittsburgh Department of Rheumatology
mi
from
Pittsburgh, PA
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
University of Pittsburgh Department of Rheumatology
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
Medical University of South Carolina
mi
from
Charleston, SC
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months
A Prospective, Observational, Single-blinded, Longitudinal MRI Study of Effect of Glatiramer Acetate on Iron Deposition in Patients With Relapsing-remitting Multiple Sclerosis Over 24 Months
Status: Enrolling
Updated:  9/27/2012
Buffalo Neuroimaging Analysis Center
mi
from
Buffalo, NY
A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months
A Prospective, Observational, Single-blinded, Longitudinal MRI Study of Effect of Glatiramer Acetate on Iron Deposition in Patients With Relapsing-remitting Multiple Sclerosis Over 24 Months
Status: Enrolling
Updated: 9/27/2012
Buffalo Neuroimaging Analysis Center
mi
from
Buffalo, NY
Click here to add this to my saved trials
Umbilical Cord Blood in the Treatment of Stroke in Children.
Safety of Autologous Human Umbilical Cord Blood in the Treatment of Stroke in Children.
Status: Enrolling
Updated:  10/2/2012
Children's Memorial Hermann Hospital; University of Texas Health Science Center - Houston
mi
from
Houston, TX
Umbilical Cord Blood in the Treatment of Stroke in Children.
Safety of Autologous Human Umbilical Cord Blood in the Treatment of Stroke in Children.
Status: Enrolling
Updated: 10/2/2012
Children's Memorial Hermann Hospital; University of Texas Health Science Center - Houston
mi
from
Houston, TX
Click here to add this to my saved trials
N-acetylcysteine (NAC) for Children With Tourette Syndrome
Double-Blind, Placebo-Controlled Trial of N-acetylcysteine (NAC) for the Treatment of Children With Tourette Syndrome
Status: Enrolling
Updated:  10/3/2012
Yale Child Study Center
mi
from
New Haven, CT
N-acetylcysteine (NAC) for Children With Tourette Syndrome
Double-Blind, Placebo-Controlled Trial of N-acetylcysteine (NAC) for the Treatment of Children With Tourette Syndrome
Status: Enrolling
Updated: 10/3/2012
Yale Child Study Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Survey on Return to Work After Stroke
Survivor Perspective on Critical Factors to Return to Work After Stroke
Status: Enrolling
Updated:  10/5/2012
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Survey on Return to Work After Stroke
Survivor Perspective on Critical Factors to Return to Work After Stroke
Status: Enrolling
Updated: 10/5/2012
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*
Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*
Status: Enrolling
Updated:  10/8/2012
Creighton University Medical Center
mi
from
Omaha, NE
Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*
Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*
Status: Enrolling
Updated: 10/8/2012
Creighton University Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Evaluation of Allergenicity of Hypoallergenic Peanut Product in Peanut Allergic Subjects
Evaluation of Allergenicity of Hypoallergenic Peanut Product in Peanut Allergic Subjects.
Status: Enrolling
Updated:  10/8/2012
Center for Environmental Medicine, Asthma and Lung Biology
mi
from
Chapel Hill, NC
Evaluation of Allergenicity of Hypoallergenic Peanut Product in Peanut Allergic Subjects
Evaluation of Allergenicity of Hypoallergenic Peanut Product in Peanut Allergic Subjects.
Status: Enrolling
Updated: 10/8/2012
Center for Environmental Medicine, Asthma and Lung Biology
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Trigeminal Nerve Stimulation for Drug Resistant Epilepsy
Trigeminal Nerve Stimulation for Epilepsy
Status: Enrolling
Updated:  10/11/2012
Olive View - UCLA Medical Center
mi
from
Sylmar, CA
Trigeminal Nerve Stimulation for Drug Resistant Epilepsy
Trigeminal Nerve Stimulation for Epilepsy
Status: Enrolling
Updated: 10/11/2012
Olive View - UCLA Medical Center
mi
from
Sylmar, CA
Click here to add this to my saved trials
Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS
Evaluation of Ubiquinol on the Association of Statins and Mitochondrial Oxidative Capacity Using 31P Magnetic Resonance Imaging
Status: Enrolling
Updated:  10/13/2012
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS
Evaluation of Ubiquinol on the Association of Statins and Mitochondrial Oxidative Capacity Using 31P Magnetic Resonance Imaging
Status: Enrolling
Updated: 10/13/2012
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Multifaceted Treatment of Catheter-related Urinary Tract Infection
Multifaceted Treatment of Catheter-related Urinary Tract Infection
Status: Enrolling
Updated:  10/15/2012
Michael E. DeBakey VA Medical Center (152)
mi
from
Houston, TX
Multifaceted Treatment of Catheter-related Urinary Tract Infection
Multifaceted Treatment of Catheter-related Urinary Tract Infection
Status: Enrolling
Updated: 10/15/2012
Michael E. DeBakey VA Medical Center (152)
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
13-week, Double-blind, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of Modified Release AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Status: Enrolling
Updated:  10/16/2012
Novartis Investigative Site
mi
from
Phoenix, AZ
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
13-week, Double-blind, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of Modified Release AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Status: Enrolling
Updated: 10/16/2012
Novartis Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
13-week, Double-blind, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of Modified Release AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Status: Enrolling
Updated:  10/16/2012
Novartis Investigative site
mi
from
Los Angeles, CA
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
13-week, Double-blind, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of Modified Release AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Status: Enrolling
Updated: 10/16/2012
Novartis Investigative site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
13-week, Double-blind, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of Modified Release AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Status: Enrolling
Updated:  10/16/2012
Novartis Investigative site
mi
from
Aurora, CO
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
13-week, Double-blind, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of Modified Release AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Status: Enrolling
Updated: 10/16/2012
Novartis Investigative site
mi
from
Aurora, CO
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
13-week, Double-blind, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of Modified Release AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Status: Enrolling
Updated:  10/16/2012
Novartis Investigative Site
mi
from
Miami, FL
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
13-week, Double-blind, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of Modified Release AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Status: Enrolling
Updated: 10/16/2012
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
13-week, Double-blind, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of Modified Release AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Status: Enrolling
Updated:  10/16/2012
Novartis Investigative site
mi
from
Gainesville, GA
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
13-week, Double-blind, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of Modified Release AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Status: Enrolling
Updated: 10/16/2012
Novartis Investigative site
mi
from
Gainesville, GA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
13-week, Double-blind, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of Modified Release AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Status: Enrolling
Updated:  10/16/2012
Novartis Investigative Site
mi
from
Chicago, IL
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
13-week, Double-blind, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of Modified Release AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Status: Enrolling
Updated: 10/16/2012
Novartis Investigative Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
13-week, Double-blind, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of Modified Release AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Status: Enrolling
Updated:  10/16/2012
Novartis Investigative Site
mi
from
Overland Park, KA
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
13-week, Double-blind, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of Modified Release AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Status: Enrolling
Updated: 10/16/2012
Novartis Investigative Site
mi
from
Overland Park, KA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
13-week, Double-blind, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of Modified Release AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Status: Enrolling
Updated:  10/16/2012
Novartis Investigative Site
mi
from
Oklahoma City, OK
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
13-week, Double-blind, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of Modified Release AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Status: Enrolling
Updated: 10/16/2012
Novartis Investigative Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
13-week, Double-blind, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of Modified Release AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Status: Enrolling
Updated:  10/16/2012
Novartis Investigative site
mi
from
Madison, WI
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
13-week, Double-blind, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of Modified Release AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Status: Enrolling
Updated: 10/16/2012
Novartis Investigative site
mi
from
Madison, WI
Click here to add this to my saved trials
Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures
Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures
Status: Enrolling
Updated:  10/21/2012
University of California, San Diego Medical Center / Neonatal Intensive Care Unit (NICU)
mi
from
San Diego, CA
Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures
Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures
Status: Enrolling
Updated: 10/21/2012
University of California, San Diego Medical Center / Neonatal Intensive Care Unit (NICU)
mi
from
San Diego, CA
Click here to add this to my saved trials
Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis
Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis
Status: Enrolling
Updated:  10/22/2012
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis
Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis
Status: Enrolling
Updated: 10/22/2012
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Vascular Effects of Attention Deficit Hyperactivity Disorder (ADHD) Medications in Youth
Vascular Consequences of ADHD Medication Use in Children and Adolescents
Status: Enrolling
Updated:  10/22/2012
Univ of Minnesota
mi
from
Minneapolis, MN
Vascular Effects of Attention Deficit Hyperactivity Disorder (ADHD) Medications in Youth
Vascular Consequences of ADHD Medication Use in Children and Adolescents
Status: Enrolling
Updated: 10/22/2012
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Effect of PBT2 in Patients With Early to Mid Stage Huntington Disease
A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability, and Efficacy of PBT2 in Patients With Early to Mid-stage Huntington Disease
Status: Enrolling
Updated:  10/22/2012
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Effect of PBT2 in Patients With Early to Mid Stage Huntington Disease
A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability, and Efficacy of PBT2 in Patients With Early to Mid-stage Huntington Disease
Status: Enrolling
Updated: 10/22/2012
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Effect of PBT2 in Patients With Early to Mid Stage Huntington Disease
A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability, and Efficacy of PBT2 in Patients With Early to Mid-stage Huntington Disease
Status: Enrolling
Updated:  10/22/2012
University of California at San Diego
mi
from
San Diego, CA
Effect of PBT2 in Patients With Early to Mid Stage Huntington Disease
A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability, and Efficacy of PBT2 in Patients With Early to Mid-stage Huntington Disease
Status: Enrolling
Updated: 10/22/2012
University of California at San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials